Clinical trial · Interventional
RN-Led Palliative and Supportive Care Intervention
Feasibility and Acceptability of A RN-Led Palliative and Supportive Care Intervention for Adults With Acute Leukemia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This single institution feasibility and acceptability study includes patients with acute leukemia which is designed to examine a novel palliative and supportive care intervention (Palliative and supportive Care inTervention; PACT) in which registered nurses (RNs), occupational therapists (OTs), and physical therapists (PTs) address the activity needs of older adults with acute leukemia during their hospital stay.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Myeloid Leukemia | Acute Myeloid Leukemia | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Palliative And supportive Care inTervention (PACT) | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Control
- description
- Patients in the control arm will receive standard of care and no intervention.
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Patients in the intervention arm will receive the PACT intervention provided by a multidisciplinary team of RNs, OTs, and PTs.
- interventionNames
- Other: Palliative And supportive Care inTervention (PACT)
Primary outcomes (8)
- measure
- Feasibility and Acceptability
- timeFrame
- Baseline
- description
- Feasibility and acceptability will be assessed as the number of participants who were approached, consented to, and eligible for the study.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
\[Patient\] Inclusion Criteria: 1. ≧60 years of age 2. Diagnosis of acute myeloid leukemia 3. Receive low-dose cytarabine or hypomethylating agent (HMA) in combination with Venetoclax chemotherapy 4. Speak and read English 5. Preference will be given to patients with care partners Exclusion Criteria: 1\. Patients receiving hospice care \[Caregiver\] Inclusion Criteria: 1. ≧18 years of age 2. Identified by patient as caregiver 3. Speak and read English
References
Publications (0)
Data not yet available